RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
The previous article demonstrated that mental illness is an expensive, sprawling problem in the American workplace. The good news is that modern treatments are varied and highly effective. Treatment of depression, in particular, has helped a large proportion of patients because of advances in the use of medications and/or psychotherapy.
Over the last 10 years, nine new antidepressants were released in the U.S. These drugs, primarily falling into a category known as selective serotonin reuptake inhibitors (SSRIs), have worked well with more tolerable side effects, greater safety and simpler dosing than their predecessors. Consequently, their use has resulted in better patient compliance and improved physician utilization. Similar advances have occurred in the adoption of newer methods of psychotherapy, such as cognitive behavioral therapy, which are now more structured and time limited.
Still, employers have a right, even a responsibility, to question approaches to mental health.
